Key result
Circulating proteomic profiling identifies 15 proteins linked to long-term cognitive outcome after ischemic stroke.
Why the study?
Do circulating neurobiological proteins predict long-term cognitive outcome after ischemic stroke?
Cohort (n=205)
Do circulating neurobiological proteins predict long-term cognitive outcome after ischemic stroke?
Answers are grounded in this paper and cite their sources.
Profiling of circulating neurobiological proteins identified 15 novel candidate biomarkers associated with long-term cognitive outcome 7 years after ischemic stroke.
The biological underpinnings of post-stroke cognitive function are largely unknown, and protein investigations can point towards important pathways for further study. We profiled plasma levels of 91 neurology-related proteins (Olink Neurology panel) and serum Neurofilament light chain (NfL) levels in 205 cases in the Sahlgrenska Academy Study on Ischemic Stroke. Blood was sampled in the acute and convalescent (3 months post-stroke) phase. Cognitive outcome was evaluated by the Barrow Neurological Institute Screen for Higher Cerebral Functions 7 years post-stroke. In linear regression models, 6 and 5 proteins in the acute and convalescent phase, respectively, were univariably associated with cognitive outcome at False Discovery Rate (FDR) < 0.05, and 9 and 8 at p < 0.05 after adjustment for age, sex, education and sampling day (model 1) and/or additional adjustment for stroke severity (model 2). Of these, 15 proteins contributed with information in multi-protein models on at least one time-point. These included brain-expressed proteoglycans (NCAN, BCAN, GPC5, SPOCK1); contactin-5 (CNTN5); metabolic enzymes (HAGH, NMNAT1); cluster of differentiation (CD)-proteins (SIGLEC1, CLEC10A, CD200R1); GDNF family receptor alpha-1 (GFR-alpha-1); brorin (VWC2); beta-nerve growth factor (beta-NGF); myostatin (GDF-8); and NfL. We identified novel candidate protein biomarkers of post-stroke cognitive outcome that likely reflect different biological processes, warranting further exploration.
No takes yet. Share an insight, caveat, or question.
Lagging et al. (2025) conducted a cohort in Ischemic stroke (n=205). Circulating neurobiological proteins was evaluated on Cognitive outcome evaluated by the Barrow Neurological Institute Screen for Higher Cerebral Functions 7 years post-stroke (p=< 0.05). Profiling 92 circulating proteins identified 15 proteins (including brain-expressed proteoglycans and NfL) associated with cognitive outcome 7 years after ischemic stroke.
Synapse has enriched 10 related papers. Consider them for comparative context: